Evidence map›Paper›PMID 42802776›Full record

ArticleJournal of the ASEAN Federation of Endocrine Societies2026

Phosphaturic Mesenchymal Tumor: From Invisibility to Bedridden Morbidity.

Ramita Mukherjee, Santosha Kumar Pattashanee, Brijesh Kumar Singh, Asuri Krishna, Sushant Soren, A Nishikant Damle, M C Sharma, V Seenu

Abstract readCase Reports
In one paragraph

Article in Journal of the ASEAN Federation of Endocrine Societies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramita MukherjeeDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Santosha Kumar PattashaneeDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Brijesh Kumar SinghDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Asuri KrishnaDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
Sushant SorenDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
A Nishikant DamleDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
M C SharmaDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.
V SeenuDepartment of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by fibroblast growth factor 23 (FGF23) secreting phosphaturic mesenchymal tumors. We report a 53-year-old man with progressive osteomalacia resulting in bedridden status. Renal phosphate wasting despite normal vitamin D, intact parathormone, and renal function raised suspicion of TIO, confirmed by elevated FGF23. However, the occult tumor was localized only by Ga-68 DOTANOC wholebody PET-CT, highlighting the diagnostic challenges in TIO.

Indexed as

HypophosphatemiaMesenchymomaNeoplasms, Connective and Soft TissueNeoplasms, Connective TissueOsteomalaciaParaneoplastic SyndromesFibroblast Growth Factor-23Fibroblast Growth FactorsHumansMaleMiddle AgedPositron Emission Tomography Computed TomographyFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsFGF23hypophosphatemiaoncogenic osteomalaciaparaneoplastic syndromephosphaturic mesenchymal tumor

Identifiers

PMID42802776
PMCPMC13616076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.